Literature DB >> 21858534

Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain's economy?

Juan Oliva-Moreno1.   

Abstract

The aim of this study is to estimate the economic impact of the non-medical costs of diseases and accidents in Spain. Its main premise sustains the idea that in addition to the number of deaths, the loss of quality of life and the pain suffered by patients and their family members as a result of diseases and accidents, there are other indicators that provide us with a better understanding of their socioeconomic impact. Our analysis provides estimates of the loss of labour productivity in Spain as a result of health problems in 2005. Our main finding suggests an estimated loss amounting to over 37,969 millions euros, of which 9,136 millions euros are due to premature deaths, 18,577 millions to permanent disability and 10,255 millions to temporary disability. The loss in labour productivity due to accidents and health problems was estimated to a figure equivalent to nearly 4.2% of the Gross Domestic Product of Spain in 2005. This study underscores the strong economic impact of non-medical costs of diseases. In addition, it stresses the need for better information systems for collecting data that is relevant to the topic at hand.

Entities:  

Mesh:

Year:  2011        PMID: 21858534     DOI: 10.1007/s10198-011-0344-9

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  28 in total

1.  Hidden costs of mental illness.

Authors:  Martin Knapp
Journal:  Br J Psychiatry       Date:  2003-12       Impact factor: 9.319

2.  The friction cost method for measuring indirect costs of disease.

Authors:  M A Koopmanschap; F F Rutten; B M van Ineveld; L van Roijen
Journal:  J Health Econ       Date:  1995-06       Impact factor: 3.883

3.  The willingness to pay for health changes, the human-capital approach and the external costs.

Authors:  M Johannesson
Journal:  Health Policy       Date:  1996-06       Impact factor: 2.980

Review 4.  Measuring and valuing productivity loss due to poor health: A critical review.

Authors:  Wei Zhang; Nick Bansback; Aslam H Anis
Journal:  Soc Sci Med       Date:  2010-11-18       Impact factor: 4.634

5.  Towards a new approach for estimating indirect costs of disease.

Authors:  M A Koopmanschap; B M van Ineveld
Journal:  Soc Sci Med       Date:  1992-05       Impact factor: 4.634

6.  The value of medical spending in the United States, 1960-2000.

Authors:  David M Cutler; Allison B Rosen; Sandeep Vijan
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

Review 7.  The contribution of health to the economy in the European Union.

Authors:  Marc Suhrcke; Martin McKee; David Stuckler; Regina Sauto Arce; Svetla Tsolova; Jørgen Mortensen
Journal:  Public Health       Date:  2006-10-04       Impact factor: 2.427

8.  [How should health and healthcare priorities be set and evaluated? Prioritization methods and regional disparities. 2008 SESPAS Report].

Authors:  Fernando I Sánchez Martínez; José María Abellán Perpiñán; Jorge E Martínez Pérez
Journal:  Gac Sanit       Date:  2008-04       Impact factor: 2.139

Review 9.  Outcome measurement in economic evaluation.

Authors:  M Johannesson; B Jönsson; G Karlsson
Journal:  Health Econ       Date:  1996 Jul-Aug       Impact factor: 3.046

Review 10.  Perspectives: an international review of the national cost estimates of mental illness, 1990-2003.

Authors:  Teh-wei Hu
Journal:  J Ment Health Policy Econ       Date:  2006-03
View more
  10 in total

1.  Crisis, suicide and labour productivity losses in Spain.

Authors:  Berta Rivera; Bruno Casal; Luis Currais
Journal:  Eur J Health Econ       Date:  2016-01-22

2.  Unobserved heterogeneity in work absence.

Authors:  María José Suárez; Cristina Muñiz
Journal:  Eur J Health Econ       Date:  2018-02-21

3.  How relevant are social costs in economic evaluations? The case of Alzheimer's disease.

Authors:  L M Peña-Longobardo; B Rodríguez-Sánchez; J Oliva-Moreno; I Aranda-Reneo; J López-Bastida
Journal:  Eur J Health Econ       Date:  2019-07-24

4.  Labour productivity losses caused by premature death associated with hepatitis C in Spain.

Authors:  Juan Oliva-Moreno; Luz M Peña-Longobardo; Sonia Alonso; Antonio Fernández-Bolaños; María Luisa Gutiérrez; Álvaro Hidalgo-Vega; Elsa de la Fuente; Conrado M Fernández-Rodríguez
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-06       Impact factor: 2.566

5.  An economic perspective on the causal explanations for the socioeconomic inequalities in health.

Authors:  Lori J Curtis
Journal:  Rev Panam Salud Publica       Date:  2018-07-06

6.  The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.

Authors:  Laura Delgado-Ortega; Almudena González-Domínguez; Josep María Borrás; Juan Oliva-Moreno; Eva González-Haba; Salomón Menjón; Pedro Pérez; David Vicente; Luis Cordero; Margarita Jiménez; Susana Simón; Álvaro Hidalgo-Vega; Carlota Moya-Alarcón
Journal:  Eur J Health Econ       Date:  2018-06-19

7.  Variability in the burden of disease estimates with or without age weighting and discounting: a methodological study.

Authors:  Oluwaseun Egunsola; Jacques Raubenheimer; Nicholas Buckley
Journal:  BMJ Open       Date:  2019-08-18       Impact factor: 2.692

8.  The cost of lost productivity due to premature lung cancer-related mortality: results from Spain over a 10-year period.

Authors:  Josep Darbà; Alicia Marsà
Journal:  BMC Cancer       Date:  2019-10-23       Impact factor: 4.430

9.  Evaluation of productivity losses due to premature mortality from colorectal cancer.

Authors:  Josep Darbà; Alicia Marsà
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

10.  Association of long working hours and health-related productivity loss, and its differential impact by income level: A cross-sectional study of the Korean workers.

Authors:  Dong-Wook Lee; Jongin Lee; Hyoung-Ryoul Kim; Mo-Yeol Kang
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.